Drug Research
Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test
Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.
Roche launched its Elecsys HCV Duo immunoassay (Elecsys) in July 2022, which is the first available immunoassay...
Drug Research
Merck and Orion Announce Global Collaboration for Oncology Drug
Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer.
Merck, known as MSD outside the United States and Canada, announced a global development...
Drug Research
Three Pharma MSMEs Programmes Launched By Indian Government
Three programmes were introduced by the Indian government on July 21st to support Micro, Small and Medium-Sized Enterprises (MSMEs) in the pharmaceutical industry. At the launch event, Mansukh Mandaviya, the Union Minister, said that the programmes call for the establishment...
Drug Research
Universal Coronavirus Monoclonal Therapy For COVID-19 Strain
Since 2019, the SARS-CoV-2 that produces COVID-19 has tragically highlighted the fragility of humanity to new coronaviruses by killing 6.3 million people globally.
In order to combat SARS-CoV-2 and all of its potentially dangerous variations, namely Beta, Gamma, Delta, Epsilon,...
Drug Research
FDA Examines 2 Other Cancer Approvals Without Revocation
The oncology division of the FDA has recently tightened regulations for expedited approvals and emphasised the significance of patient survival data. Several businesses promptly followed suit and withdrew questionable indicators when the agency applied more pressure. However, some businesses...
Drug Research
COVID-19 Reinfections Are Augmented By BA.5, But Not Usually
It's not your imagination: As infections from the fast mutating BA.5 coronavirus subvariant rise throughout the United States, more people are becoming infected with COVID-19 for the second or third time. However, on aggregate, these reinfections do not appear...
Drug Research
FDA Approves Liquid Epilepsy Drug From Azurity After Denial
On the second attempt, Azurity Pharmaceuticals was able to secure an FDA nod for its zonisamide oral suspension, making it the first firm to do so in the United States. In February 2021, Massachusetts-based Azurity acquired the rights to the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
